To investigate an interaction between the G894T polymorphism of endothelial nitric oxide synthase (eNOS) gene and the C825T polymorphism of GNB3 in the risk for essential hypertension (EH).
P-433 SYNERGISTIC EFFECT BETWEEN ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE T786C AND 4B/A POLYMORPHISMS IN PATIENTS WITH ESSENTIAL HYPERTENSION
Aim: To investigate an interaction between eNOS gene T786C and 4b/a polymorphisms in the risk for essential hypertension (EH).
Methods: Polymerase chain reaction (PCR)combined with restriction enzyme digestion was used to detect the T786C and 4b/a polymorphisms of eNOS gene in 189 normotensive controls and 310 hypertensive patients.
Results: The frequencies of a allele , abϩaa genotype and C allele , CCϩCT genotype in EH were significantly higher than in control group respectively;The odds ratio(OR) estimated by combined analysis with eNOS 786C and a allele (2.51) was markedly increased compared with that estimated alone from either eNOS 786C (0.542) or a allele(0.389).
Conclusions: eNOS 786C and a allele should be a risk factor for EH in chinese Han nationality;there was a significant synergistic effects of eNOS 786C and a allele in EH. The aim of this study was to determine whether the aminopeptidase inhibitor arphamenine A could affect the collagen production and expression in control and TGF-beta1-treated cardiac fibroblasts.Cardiac fibroblasts from passage 2 from normal male adult rats (nϭ5) were cultured to confluency, incubated with(out) 600 pmol/l TGF-beta1 for 2 days in serum-free Dulbecco's modified Eagles's medium and then incubated with 100 mol/l arphamenine A for 1 day in this medium with added ascorbic acid, beta-aminoproprionitrile and titriated proline. Soluble collagen was measured in the conditioned medium and nonsoluble collagen in the cell layer. Aminopeptidase activity was estimated by spectrophotometric determination of the liberation of p-nitroaniline from alanineand arginine-p-nitroanilide. Matrix metalloproteinase (MMP) and lysyl oxidase activity were assayed in the conditioned medium. A semiquantitative reverse transcription polymerase chain reaction was used to determine the expression of lysyl oxidase and collagen type I and III. Arphamenine A dose-dependently inhibited the basal and TGF-beta1-stimulated aminopeptidase activity. Arphamenine A reduced the soluble and nonsoluble collagen production in control and TGF-beta1-treated cardiac fibroblasts, while it decreased the collagen type I and III expression only in TGF-beta1-fibroblasts. Lysyl oxidase, MMP-1 and MMP-2 activity were inhibited by arphamenine A in the conditioned media of control and TGF-beta1-treated cardiac fibroblasts, while MMP-13 and TIMP-2 were not affectyed by arphamenine A.Our data show that the specific aminopeptidase inhibitor arphamenine A reduces the collagen production in cardiac fibroblasts and that this reduction is accompanied by a pronounced inhibition of lysyl oxidase. The aim of this study was to determine whether (amino)peptidase inhibition could affect the collagen gel contraction in basal (control) cardiac fibroblasts. Cardiac fibroblasts (from 6 normal male adult rats) were cultured to confluency in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS). These fibroblasts (100,000 cells) were then further incubated in a floating collagen gel lattice with various concentrations (1, 10, 50, 100 or 300 mol/l) of imipramine, a puromycin-sensitive aminopeptidase inhibitor, or with des-Tyr-Met-enkephalin (10 or 100 mol/l), a neutral endopeptidase (NEP-24.11) or enkephalinase inhibitor, and compared with the NEP inhibitors phosphoramidon or thiorphan (10 mol/l) for 3 days in DMEM without FBS. The contraction of the collagen gel lattice by cardiac fibroblasts was determined by measuring the gel volume with titriated water. The original gel volume of the hydrated collagen gel in the absence of fibroblasts averaged 240.1 Ϯ3.2 l and decreased to 148.1 Ϯ 9.7 l in control fibroblasts. Imipramine at a concentration of 1 mol/l did not affect the gel volume of control fibroblasts (146.7 Ϯ 9.6 l). The gel volume is however increased with higher concentrations of imipramine to , respectively ,164.7 Ϯ 9.6, 222.0 Ϯ 12.9, 238.3 Ϯ 1.4 and 243.8 Ϯ 5.4 l with 10, 50, 100 and 300 mol/l. The latter 2 concentrations of imipramine even completely inhibited the collagen gel contraction in fibroblasts and this
